Indaptus Therapeutics

INDPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$157.226 M

$1.18 -5.60%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$20.8M

Loss-making

Shares outstanding

2,242,324

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#279OnKure TherapeuticsOKUR$167.7M
#280Kazia TherapeuticsKZIA$158.7M
#281Indaptus TherapeuticsINDP$157.2M
#282Jyong BiotechMENS$154.3M
#283Milestone PharmaceuticalsMIST$151.9M

Where these numbers come from

Share counts and financials for Indaptus Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.